Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Trial Summary
What is the purpose of this trial?
This trial tests a new drug, KLS-2031, on adults with lower back nerve pain. The drug is injected into the spine to see if it can safely reduce pain by targeting the nerves directly.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research Team
Todd Bertoch, MD
Principal Investigator
JBR Clinical Research
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single ascending dose of KLS-2031 or placebo via transforaminal epidural injection
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- KLS-2031
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kolon Life Science
Lead Sponsor